Microarray analysis of human kidney biopsies in the Nephroseq database1 revealed a higher expression of SREBF1 and SREBF2 in patients with CKD or diabetic kidney disease (DKD) than in normal patients according to the results reported in Ju CKD Glom (Ju et al., 2013), Nakagawa CKD (Nakagawa et al., 2015), and Woroniecka Diabetes Glom (Woroniecka et al., 2011; Na et al., 2015). Here, SREBF2 is linked to diabetic kidney disease.